Related references
Note: Only part of the references are listed.Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease
Clas-Goran af Bjorkesten et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Irritable Bowel Syndrome-Type Symptoms in Patients With Inflammatory Bowel Disease: A Real Association or Reflection of Occult Inflammation?
John Keohane et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Can calprotectin predict relapse risk in inflammatory bowel disease?
Renata D'Inca et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2008)
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings
Toino Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Oratory markers in IBD: Magic, or unneccessary toys?
S Vermeire et al.
GUT (2006)
IBS-like symptoms in patients with inflammatory bowel disease in remission; Relationships with quality of life and coping behavior
IM Minderhoud et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences
EV Loftus
GASTROENTEROLOGY (2004)
A simple method for assessing intestinal inflammation in Crohn's disease
J Tibble et al.
GUT (2000)